Gilead closes in on second CAR-T approval in US

Gilead closes in on second CAR-T approval in US

Source: 
Pharmaforum
snippet: 

The FDA is due to decide by 10 August whether it will approve a second CAR-T therapy from Gilead’s Kite unit intended to treat mantle cell lymphoma (MCL).